Dahong M. Yao
Shenzhen, 518060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: July 08, 2026
Complex phloroglucinols from glandular hairs of Mallotus philippensis and their antiviral activities.
Journal: Bioorganic chemistry
Published: March 19, 2026
Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo.
Journal: Bioorganic & medicinal chemistry
Published: February 06, 2026
ACLY Safeguards Copper Homeostasis to Sustain Brown Adipose Tissue Thermogenesis and Restrain Diet-Induced Obesity.
Journal: Research (Washington, D.C.)
Published: January 03, 2026
Metabolomics-guided discovery of previously undescribed lupane-type triterpenoids with anti-inflammatory activity from Mallotus repandus (Willd.) Müll. Arg.
Journal: Phytochemistry
Published: December 29, 2025
(+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolism.
Journal: Acta pharmaceutica Sinica. B
Published: June 24, 2025
Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-β/SMADS signaling pathway and glutathione metabolism.
Journal: International immunopharmacology
Published: April 03, 2025
Mechanism of Eucalyptus oil in alleviating UUO-induced renal fibrosis revealed by transcriptomics and metabolomics.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 24, 2025
Rosiridin reduces Idiopathic Pulmonary Fibrosis by inhibiting the STAT3/NFκB/SMAD3 signaling pathways.
Journal: Journal of pharmacological sciences
Published: January 20, 2025
Discovery of a Novel Selective PAK1/HDAC6/HDAC10 Inhibitor ZMF-25 that Induces Mitochondrial Metabolic Breakdown and Autophagy-Related Cell Death in Triple-Negative Breast Cancer.
Journal: Research (Washington, D.C.)
Published: January 15, 2025
Design, synthesis and biological evaluation of a novel PAK1 degrader for the treatment of triple negative breast cancer.
Journal: Bioorganic & medicinal chemistry
Published: June 21, 2024
Last Updated: 09/26/2026